We are live on ! Find out more
AS

Altshuler Shaham Portfolio holdings

AUM $8.04B
1-Year Est. Return 44.04%
This Fund
S&P 500
This Quarter Est. Return
+0.13%
1 Year Est. Return
+44.04%
3 Year Est. Return
+108.34%
5 Year Est. Return
+71.14%
10 Year Est. Return
AUM
$2.38B
AUM Growth
+$188M
Cap. Flow
+$189M
Cap. Flow %
7.96%
Top 10 Hldgs %
79.65%
Holding
417
New
125
Increased
152
Reduced
62
Closed
61

Sector Composition

Rank Sector Weight
1 Technology 31.7%
2 Consumer Discretionary 16.23%
3 Industrials 7.87%
4 Real Estate 4.08%
5 Healthcare 1.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MESO
251
Mesoblast
MESO
$2.14B
$16K ﹤0.01%
425
MORN icon
252
Morningstar
MORN
$7.76B
$16K ﹤0.01%
+113
New +$15.6K
ADAM
253
Adamas Trust
ADAM
$907M
$16K ﹤0.01%
634
-29
-4% -$716
PEGA icon
254
Pegasystems
PEGA
$5.51B
$16K ﹤0.01%
+460
New +$16.4K
RNG icon
255
RingCentral
RNG
$5.66B
$16K ﹤0.01%
+136
New +$15.7K
RWT
256
Redwood Trust
RWT
$599M
$16K ﹤0.01%
972
-28
-3% -$453
TRTX
257
TPG RE Finance Trust
TRTX
$616M
$16K ﹤0.01%
806
+20
+3% +$392
ZNGA
258
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
$15K ﹤0.01%
2,527
+396
+19% +$2.33K
MLAB icon
259
Mesa Laboratories
MLAB
$633M
$13K ﹤0.01%
52
-150
-74% -$34.9K
STE icon
260
Steris
STE
$23B
$13K ﹤0.01%
+84
New +$11.2K
ANIP icon
261
ANI Pharmaceuticals
ANIP
$1.72B
$12K ﹤0.01%
+142
New +$10.1K
CRVL icon
262
CorVel
CRVL
$3.25B
$12K ﹤0.01%
399
+27
+7% +$665
GKOS icon
263
Glaukos
GKOS
$11.2B
$12K ﹤0.01%
153
-130
-46% -$9.33K
NVCR icon
264
NovoCure
NVCR
$2.02B
$12K ﹤0.01%
186
-206
-53% -$10.4K
TFX icon
265
Teleflex
TFX
$5.82B
$12K ﹤0.01%
35
+8
+30% +$2.42K
VCYT icon
266
Veracyte
VCYT
$3.42B
$12K ﹤0.01%
434
+29
+7% +$724
VAR
267
DELISTED
Varian Medical Systems, Inc.
VAR
$12K ﹤0.01%
90
-50
-36% -$6.68K
A icon
268
Agilent Technologies
A
$42.2B
$11K ﹤0.01%
150
-88
-37% -$6.52K
ABT icon
269
Abbott
ABT
$193B
$11K ﹤0.01%
131
-112
-46% -$8.82K
BAX icon
270
Baxter International
BAX
$14B
$11K ﹤0.01%
134
+29
+28% +$2.25K
BIO icon
271
Bio-Rad Laboratories Class A
BIO
$9.66B
$11K ﹤0.01%
+35
New +$10.5K
BSX icon
272
Boston Scientific
BSX
$74.9B
$11K ﹤0.01%
261
-210
-45% -$8.08K
CHE icon
273
Chemed
CHE
$7.02B
$11K ﹤0.01%
30
+6
+25% +$2K
COO icon
274
Cooper Companies
COO
$14.9B
$11K ﹤0.01%
132
+24
+22% +$1.8K
DGX icon
275
Quest Diagnostics
DGX
$26.1B
$11K ﹤0.01%
+105
New +$10.1K

Similar funds

Altshuler Shaham's Q2 2019 Portfolio in Review

As of Q2 2019, Altshuler Shaham held 417 positions worth $2.38B, up 8.6% from $2.19B the previous quarter. Its ten largest holdings account for 80% of the portfolio.

Altshuler Shaham deployed $189M of net new capital in Q2 2019, opening 125 new positions and adding to 152 existing holdings. Its largest new stake was F5: 9,774 shares worth $1.42M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 28% a quarter earlier, followed by Consumer Discretionary and Industrials.

On the sell side, the largest reduction was Alibaba, an estimated $27.6M trimmed.

  • Altshuler Shaham's largest Q2 2019 buy was F5: 9,774 shares worth $1.42M.
  • Altshuler Shaham added most to Cisco in Q2 2019, an estimated $63.4M increase.
  • Altshuler Shaham's biggest Q2 2019 reduction was Alibaba, cutting an estimated $27.6M.
  • Altshuler Shaham fully exited Builders FirstSource in Q2 2019, selling an estimated $29.5M.
  • Altshuler Shaham's ten largest holdings make up 80% of its $2.38B portfolio in Q2 2019.
  • Altshuler Shaham opened 125 new positions and closed 61 in Q2 2019.
  • Altshuler Shaham's portfolio value rose 8.6% quarter-over-quarter to $2.38B.

Based on Altshuler Shaham's 13F filing for Q2 2019, filed 6 Aug 2019.